Article ISI
MULTIPLE SCLEROSIS AND RELATED DISORDERS  (2020)

Multiple sclerosis and related disorders: Short report peripheral vascular events in a real-world cohort of multiple sclerosis patients using Fingolimod

Pelayo, Carolina; Soler, Bernardita; Vergara, Elizabeth; Cárcamo, Claudia

Abstract

Background: Fingolimod is a high-efficacy disease-modifying therapy for multiple sclerosis (MS) and was the first oral treatment approved for the disease. Adverse events include bradyarrhythmia, hypertension, macular oedema and increased risk of infections, mainly due to its main mechanism of action, the non-selective modulation of sphingosine-1-phosphate receptor.

Más información

Título según WOS: Multiple sclerosis and related disorders: Short report peripheral vascular events in a real-world cohort of multiple sclerosis patients using Fingolimod
Título de la Revista: MULTIPLE SCLEROSIS AND RELATED DISORDERS
Volumen: 45
Editorial: ELSEVIER SCI LTD
Fecha de publicación: 2020
DOI:

10.1016/J.MSARD.2020.102411
Notas: ISI